Aclarion Inc

-0.08 (-9.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.43M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.02 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$1.01
50-Day MA$1.04
200-Day MAN/A
See more pivots

Aclarion Inc Stock, NASDAQ:ACON

951 Mariners Island Boulevard, Suite 300, San Mateo, California 94404
United States of America
Phone: +1.650.241.1741
Number of Employees: 6


Aclarion, Inc. is a healthcare technology company, which engages in the provision of leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It offers utilizing Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCANâ„¢ Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in San Mateo, CA.